Southwest Michigan Life Science Region Offers Virtual Visit Oct. 9

Share Article

Southwest Michigan Innovation Center graduate PharmOptima offers prime example of region's continued 125-year success and growth of life sciences in the region.

Pharmoptima

PharmOptima, a contract research organization, is encouraging other companies and entrepreneurs in the life sciences field to attend an online one-day visit to the burgeoning Kalamazoo life science region, hosted by the firm's "alma mater," the Southwest Michigan Innovation Center.

"The Southwest Michigan Innovation Center is celebrating its 10th anniversary this year. Part of that celebration is a unique 'Virtual Visit' being held Oct. 9," explained A Christian Schauer, CPA, President and Chief Executive Officer of PharmOptima. “As an SMIC graduate, PharmOptima is very excited to participate in the Virtual Visit to showcase not only our capabilities in ocular PK/ADME and biomarker development but the life science capabilities of Southwest Michigan in general."

The Innovation Center is hosting "Leading Life Sciences: A Virtual Visit" beginning at 2:30 p.m. Oct. 9. There is no cost to attend, and no need for visitors to leave their desk. Through the convenience of their own computers, visitors can interact with all exhibitors including PharmOptima, the Innovation Center and other regional companies that provide life science CRO services and IP investment opportunities.

PharmOptima, a clinical research organization formed by a group of scientists with extensive experience in major pharmaceutical companies, first opened for business at the Innovation Center in 2003, the year the Center opened. The business incubator supported the company as it developed and grew to the point that it graduated from the center and entered its own building and laboratories in nearby Portage.

The virtual visit will provide ample time for group and private chat sessions to allow visitors to meet representatives from the region's life science firms and discover opportunities that fit their needs. PharmOptima participation will include valuable information regarding its patent pending Spinal Muscular Atrophy assay as well as its expanded ocular efficacy offerings.

This event will share the legacy, strengths and opportunities for bioscience entrepreneurs, startups and investors looking for the right place and right ideas to engage their enterprise. Representatives from the Innovation Center and regional companies demonstrate the area's building blocks of bioscience success – the space, services and expertise to benefit anyone pursuing life sciences innovation, including venture capital and angel investors, economic development groups, IP startups, university technology transfer offices, patent attorneys, contract research organizations, life science recruiters and placement specialists, and many more.

Virtual visitors will see that the 125+ year history of life science excellence is alive and well in Kalamazoo.

For more information and to register:

http://www.kalamazooscience.com/virtual-1.

About PharmOptima LLC
PharmOptima is a 10 year old preclinical Contract Research Organization founded and operated by scientists with extensive experience from major pharmaceutical companies. PharmOptima is recognized as the premier CRO conducting Spinal Muscular Atrophy research. The company’s in vivo research services include delivery, efficacy, tolerance, ADME and pharmacokinetics. Their in vitro expertise includes biochemistry, recombinant proteins: cloning and expression, cell-based assays, immunosorbent assays (electrochemiluminescence MSD formats and traditional ELISA and) and biomarker research. Being owned and operated by scientists with extensive industry experience, they have first hand experience on both sides of the sponsor/CRO relationship and understand the difficulties and pressures sponsors face and work with their sponsors to move projects forward as efficiently as possible while also being mindful of budget constraints.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lance Martin
Visit website